DE2840910A1 - 7-dialkylamino-6-halogen-4-oxo-1,4- dihydro-3-chinolin-carbonsaeuren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel - Google Patents

7-dialkylamino-6-halogen-4-oxo-1,4- dihydro-3-chinolin-carbonsaeuren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Info

Publication number
DE2840910A1
DE2840910A1 DE19782840910 DE2840910A DE2840910A1 DE 2840910 A1 DE2840910 A1 DE 2840910A1 DE 19782840910 DE19782840910 DE 19782840910 DE 2840910 A DE2840910 A DE 2840910A DE 2840910 A1 DE2840910 A1 DE 2840910A1
Authority
DE
Germany
Prior art keywords
oxo
dihydro
quinoline
piperazinyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19782840910
Other languages
German (de)
English (en)
Inventor
Marcel Pesson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Roger Bellon SA
Original Assignee
Laboratoire Roger Bellon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB39197/77A external-priority patent/GB1598915A/en
Application filed by Laboratoire Roger Bellon SA filed Critical Laboratoire Roger Bellon SA
Publication of DE2840910A1 publication Critical patent/DE2840910A1/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19782840910 1977-09-20 1978-09-20 7-dialkylamino-6-halogen-4-oxo-1,4- dihydro-3-chinolin-carbonsaeuren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel Granted DE2840910A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB39197/77A GB1598915A (en) 1977-09-20 1977-09-20 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them
GB1298378 1978-04-03

Publications (1)

Publication Number Publication Date
DE2840910A1 true DE2840910A1 (de) 1979-04-05

Family

ID=26249396

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782840910 Granted DE2840910A1 (de) 1977-09-20 1978-09-20 7-dialkylamino-6-halogen-4-oxo-1,4- dihydro-3-chinolin-carbonsaeuren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Country Status (5)

Country Link
DE (1) DE2840910A1 (nl)
ES (1) ES473486A1 (nl)
FR (2) FR2403339A1 (nl)
NL (1) NL190520C (nl)
SE (1) SE444566B (nl)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2939786A1 (de) * 1978-09-29 1980-04-10 Kyorin Seiyaku Kk Chinolincarbonsaeurederivate und ihre verwendung
EP0049355A1 (de) * 1980-09-03 1982-04-14 Bayer Ag 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-(naphthyridin oder chinolin)-3-carbonsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0117473A1 (de) * 1983-02-25 1984-09-05 Bayer Ag Chinoloncarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0117474A1 (de) * 1983-02-25 1984-09-05 Bayer Ag Chinoloncarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0126355A1 (de) * 1983-05-18 1984-11-28 Bayer Ag 7-Amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0131839A1 (en) * 1983-07-18 1985-01-23 Abbott Laboratories Quinoline antibacterial compounds
WO1987003595A1 (en) 1985-12-09 1987-06-18 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Norfloxacin intermediate
US4758567A (en) * 1985-11-19 1988-07-19 Rottapharm S.P.A. 7-(4-amino-piperazinyl)- or 7-(4-chloro-piperazinyl)quinolinone and azaquinolinone derivatives and pharmaceutical compositions containing them
LT3084B (en) 1992-12-11 1994-11-25 Krka Tovarna Zdravil Process for preparing 1-substituted-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid,a novel intermediate useful in said process, and a process for preparing said intermediate
LT3274B (en) 1987-12-31 1995-05-25 Krka Tovarna Zdravil Process for preparing 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid
WO2010131054A1 (en) 2009-05-15 2010-11-18 Bradford Pharma Limited Redox drug derivatives
WO2013068948A1 (en) 2011-11-08 2013-05-16 Actelion Pharmaceuticals Ltd 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1979001144A1 (en) * 1978-05-30 1979-12-27 Fosroc International Ltd Anchoring cartridges
JPS5649382A (en) * 1979-09-28 1981-05-02 Dainippon Pharmaceut Co Ltd 6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt
SE440354B (sv) * 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
ES2186550B2 (es) * 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5049286A (nl) * 1973-09-04 1975-05-01
JPS5365887A (en) * 1976-11-22 1978-06-12 Kyorin Seiyaku Kk Substituted quinoline*arboxylate and process for preparing same
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
FR2424919B1 (fr) * 1978-05-03 1980-10-31 Kyorin Seiyaku Kk Acide quinoleinecarboxylique substitue et ses derives et leur utilisation comme agents antibacteriens

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2939786A1 (de) * 1978-09-29 1980-04-10 Kyorin Seiyaku Kk Chinolincarbonsaeurederivate und ihre verwendung
DE2939786C2 (de) * 1978-09-29 1986-10-09 Kyorin Seiyaku K.K., Tokio/Tokyo Chinolincarbonsäure- und Naphthyridincarbonsäurederivate und ihre Verwendung
EP0049355A1 (de) * 1980-09-03 1982-04-14 Bayer Ag 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-(naphthyridin oder chinolin)-3-carbonsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0117474A1 (de) * 1983-02-25 1984-09-05 Bayer Ag Chinoloncarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0117473A1 (de) * 1983-02-25 1984-09-05 Bayer Ag Chinoloncarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0126355A1 (de) * 1983-05-18 1984-11-28 Bayer Ag 7-Amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0131839A1 (en) * 1983-07-18 1985-01-23 Abbott Laboratories Quinoline antibacterial compounds
US4758567A (en) * 1985-11-19 1988-07-19 Rottapharm S.P.A. 7-(4-amino-piperazinyl)- or 7-(4-chloro-piperazinyl)quinolinone and azaquinolinone derivatives and pharmaceutical compositions containing them
WO1987003595A1 (en) 1985-12-09 1987-06-18 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Norfloxacin intermediate
LT3274B (en) 1987-12-31 1995-05-25 Krka Tovarna Zdravil Process for preparing 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid
LT3084B (en) 1992-12-11 1994-11-25 Krka Tovarna Zdravil Process for preparing 1-substituted-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid,a novel intermediate useful in said process, and a process for preparing said intermediate
WO2010131054A1 (en) 2009-05-15 2010-11-18 Bradford Pharma Limited Redox drug derivatives
WO2013068948A1 (en) 2011-11-08 2013-05-16 Actelion Pharmaceuticals Ltd 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
US9079922B2 (en) 2011-11-08 2015-07-14 Actelion Pharmaceuticals Ltd 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

Also Published As

Publication number Publication date
FR2498931A1 (fr) 1982-08-06
NL190520C (nl) 1994-04-05
NL7809591A (nl) 1979-03-22
ES473486A1 (es) 1979-11-01
FR2403339A1 (fr) 1979-04-13
SE7809411L (sv) 1979-03-21
FR2498931B1 (nl) 1984-02-10
SE444566B (sv) 1986-04-21
FR2403339B1 (nl) 1982-09-17
NL190520B (nl) 1993-11-01

Similar Documents

Publication Publication Date Title
DE3433924C2 (nl)
DE2840910A1 (de) 7-dialkylamino-6-halogen-4-oxo-1,4- dihydro-3-chinolin-carbonsaeuren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE2939786C2 (de) Chinolincarbonsäure- und Naphthyridincarbonsäurederivate und ihre Verwendung
US4292317A (en) 1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
EP0049355B1 (de) 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-(naphthyridin oder chinolin)-3-carbonsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0259804B1 (de) Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte
DE3031767A1 (de) Chinolincarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung
DE3786843T2 (de) Chinolincarbonsäurederivate.
EP0126355A1 (de) 7-Amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
DE69019859T2 (de) Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe.
EP0276700A1 (de) 8-Cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende antibakterielle Mittel
EP0206101A1 (de) Verfahren zur Herstellung von 1,8-verbrückten 4-Chinolon-3-carbonsäuren
DE3205655C2 (nl)
EP0155587B1 (de) 1,7-Diamino-1,4-dihydro-4-oxo-3-(aza) chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie ihre Verwendung bei der Bekämpfung bakterieller Erkrankungen
EP0224178B1 (de) 1-Cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
DE69004815T2 (de) 1,8-Benzonaphthyridinderivate, ihre Herstellung und diese enthaltende Zusammensetzungen.
EP0253235B1 (de) 1,8-verbrückte 4-Chinoloncarbonsäuren und diese enthaltende Arzneimittel
EP0191390B1 (de) 1-Cyclopropyl-1,4-dihydro-4-oxo-7-[4-(2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl]-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0235676B1 (de) 7-(1-Pyrrolidinyl)-chinoloncarbonsaeure-Derivate
DE3880953T2 (de) Chinolinderivate, Verfahren zur Herstellung davon und diese enthaltendes antibakterielles Mittel.
GB1598915A (en) 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them
DE3686201T2 (de) Benzo(i,j)chinolizin-2-carbonsaeurederivate, ihre salze und hydrate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
DE1620151B1 (de) 10-Piperazino-dibenzo(a,d)cycloheptadienderivate und Verfahren zu ihrer Herstellung
DE2340217A1 (de) 3-benzoylthiophene, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3635218A1 (de) 7-amino-1-cyclopropyl-8-chlor-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8310 Action for declaration of annulment
8313 Request for invalidation rejected/withdrawn